Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi announced that the US ...

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s stance on vaccines ...

The FDA on Wednesday granted accelerated approval to Regeneron ’s bispecific antibody linvoseltamab for the treatment of patients with relapsed or refractory multiple myeloma. The pharma will market ...

Markets Company Close Updates Company Close Updates Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day By MarketWatch Automation Published: July 2, 2025, 4:46 p.m ...

Lynozyflic is one of two bispecific antibodies Regeneron hopes will lift its oncology business. Meanwhile, IGM is the latest struggling biotech to agree to a buyout deal from Concentra.

By Colin Kellaher Regeneron Pharmaceuticals has won Food and Drug Administration accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.

Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.